Long-term Follow-up from Qualitative Interviews of Patients with Relapsed or Refractory Large B-Cell Lymphoma on Their Treatment Experience While Enrolled in a Lisocabtagene Maraleucel Study

被引：0
|
作者：
Barba, Pere [1 ]
Lanar, Sally [2 ]
Liu, Fei Fei [3 ]
Eliason, Laurie [3 ]
Askew, Kshawna [4 ]
Devlen, Jennifer [5 ]
Furustrand, Ulrika [3 ]
Kostic, Ana [3 ]
机构：
[1] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Barcelona, Spain
[2] ICON Plc, Lyon, France
[3] Bristol Myers Squibb, Princeton, NJ USA
[4] ICON Plc, Winston Salem, NC USA
[5] ICON Plc, Raleigh, NC USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-178858
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001
    Abramson, Jeremy S.
    Palomba, M. Lia
    Gordon, Leo I.
    Lunning, Matthew
    Wang, Michael
    Arnason, Jon
    Purev, Enkhtsetseg
    Maloney, David G.
    Andreadis, Charalambos
    Sehgal, Alison
    Solomon, Scott R.
    Ghosh, Nilanjan
    Dehner, Christine
    Kim, Yeonhee
    Ogasawara, Ken
    Kostic, Ana
    Siddiqi, Tanya
    BLOOD, 2024, 143 (05) : 404 - 416
  • [2] Lisocabtagene Maraleucel Approved for Use in Relapsed/Refractory Large B-Cell Lymphoma
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (03) : 175 - 175
  • [3] Lisocabtagene maraleucel for relapsed or refractory large B-cell non-Hodgkin lymphoma
    Mohty, Razan
    Vanegas, Yenny Moreno
    Chavez, Julio C.
    Kharfan-Dabaja, Mohamed A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (02) : 121 - 126
  • [4] Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B-cell lymphoma in an adolescent patient
    Lee, Dasom
    Goyal, Anmol
    Wang, William L.
    Ananth, Snegha
    Lau, Eric
    Binkley, Michael S.
    Bharadwaj, Sushma
    Dahiya, Saurabh
    EJHAEM, 2024, 5 (01): : 153 - 156
  • [5] Tisagenlecleucel and Lisocabtagene Maraleucel: Comparative Efficacy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Schuster, Stephen J.
    Zhang, Jie
    Yang, Hongbo
    Agarwal, Abhijit
    Tang, Wenxi
    Prieto, Marcela Martinez
    Bollu, Vamsi
    Kuzan, David
    Maziarz, Richard
    Kersten, Marie Jose
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S380 - S381
  • [6] Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma
    Patrick, Donald L.
    Powers, Annette
    Jun, Monika Parisi
    Kim, Yeonhee
    Garcia, Jacob
    Dehner, Christine
    Maloney, David G.
    BLOOD ADVANCES, 2021, 5 (08) : 2245 - 2255
  • [7] Interviews of Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) Enrolled in 2 Lisocabtagene Maraleucel (liso-cel) Trials on Their Treatment Experience for 3 Months after Infusion
    Siddiqi, Tanya
    Jaeger, Ulrich
    Moshkovich, Olga
    Braverman, Julia
    Liu, Fei Fei
    Lanar, Sally
    Miera, Matthew
    Shah, Selam
    Devlen, Jennifer
    Salles, Gilles
    BLOOD, 2021, 138
  • [8] Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell Lymphoma: Real World Analysis from the Cell Therapy Consortium
    Riedell, Peter A.
    Grady, Connor
    Nastoupil, Loretta J.
    Luna, Alejandro
    Ahmed, Nausheen
    Maziarz, Richard T.
    Hu, Marie
    Brower, Jamie
    Hwang, Wei-Ting
    Schuster, Stephen J.
    Chen, Andy
    Oluwole, Olalekan O.
    Bachanova, Veronika
    McGuirk, Joseph P.
    Perales, Miguel-Angel
    Bishop, Michael R.
    Porter, David L.
    BLOOD, 2023, 142
  • [9] Long-Term Follow-up of Tisagenlecleucel in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Updated Analysis of Juliet Study
    Schuster, Stephen J.
    Bishop, Michael R.
    Tam, Constantine S.
    Borchmann, Peter
    Jaeger, Ulrich
    Waller, Edmund K.
    Holte, Harald
    McGuirk, Joseph
    Jaglowski, Samantha
    Tobinai, Kensei
    Andreadis, Charalambos
    Fleury, Isabelle
    Mielke, Stephan
    Teshima, Takanori
    Westin, Jason R.
    Bachanova, Veronika
    Foley, Stephen Ronan
    Ho, Joy
    Magenau, John M.
    Wagner-Johnston, Nina
    Kato, Koji
    Kersten, Marie Jose
    van Besien, Koen
    Chu, Jufen
    Jary, Aline
    Anak, Oezlem
    Salles, Gilles A.
    Maziarz, Richard T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [10] In Vivo Cellular Expansion of Lisocabtagene Maraleucel and Association With Efficacy and Safety in Relapsed/Refractory Large B-Cell Lymphoma
    Ogasawara, Ken
    Lymp, James
    Mack, Timothy
    Dell'Aringa, Justine
    Huang, Chang-pin
    Smith, Jeff
    Peiser, Leanne
    Kostic, Ana
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (01) : 81 - 89
12345